TTRX — Turn Therapeutics Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 2023016 ·
Last close
$8.55
Market Cap
$261.40M
52W High
$16.45
52W Low
$2.57
ADV30
99,462
Next earnings
2026-11-09
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -1,984,442 -6,230,868 16,349,722 10,363,975 10,657,545
Jun 2026 0 — -1,628,060 -5,849,734 16,960,719 10,288,510 16,273,831
Mar 2026 0 — -1,246,143 -970,972 18,644,136 11,217,671 12,526,588
Dec 2025 0 — -2,193,570 279,070 12,162,241 5,076,144 7,475,518

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,281,841
Investing CF
$-65,606
Financing CF
$12,605,266
CapEx
$-65,606
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.50
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-35,441,826
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-10,957,433
Pretax Income TTM
$-12,772,504
Interest Exp TTM
$582,567
Analysts
2

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -5,858,648 -3,194,080 12,162,241 7,475,518 4,686,723 -2,562,901
Dec 2024 0 -1,797,124 -1,768,415 2,048,889 2,226,321 -177,432 -1,361,305
Dec 2023 0 -2,308,149 -2,292,267 2,013,560 1,927,792 85,768 -1,377,680

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$16,960,719
Forward EPS
$-0.15

Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $15.00 · spot: $8.89 · call volume: 1 · put volume: 6

Peers — same industry

TickerNameMarket CapLastDaily %
QTTB Q32 Bio Inc. $258.24M $8.63 —
ENTA ENANTA PHARMACEUTICALS INC $253.10M $8.69 —
CAMP Camp4 Therapeutics Corp $251.02M $4.00 —
NWBO NORTHWEST BIOTHERAPEUTICS INC $250.73M $0.15 —
GLSI Greenwich LifeSciences, Inc. $274.48M $18.70 —

News headlines (Yahoo Finance, 1h cache)

Turn Therapeutics to Present at Jefferies Global Healthcare Conference in London
2026-11-16 12:00 · Yahoo
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
2026-11-09 12:00 · Yahoo
Turn Therapeutics’ GX-03 Earns "Developmental Immunology Solution of the Year" in 2026 BioTech Breakthrough Awards Program
2026-11-05 13:00 · Yahoo
U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat
2026-10-21 20:01 · Yahoo
A CEO, an ex-CDC director and an ex-FDA commissioner walk into a biotech…
2026-10-21 13:00 · Yahoo
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
2026-09-09 12:00 · Yahoo
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
2026-08-12 20:30 · Yahoo
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
2026-07-11 17:02 · Yahoo
Turn Therapeutics’ stock jumps on AD data and trial expansion
2026-07-08 11:17 · Yahoo
Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic Dermatitis
2026-07-07 12:56 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.